Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1009190
Name of medicinal product: DEPO-MEDROL
Active substances:
Methylprednisolone
Estonian, English, Latin
ATC code: H02AB04
Dosage form: suspension for injection
Route of administration: intraarticular use; periarticular use; intramuscular use; intralesional use; intrabursal use
Strengh: 40mg 1ml
Amount in package: 1ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication:
Safety features: Yes
Summary of product characteristics (SPC):  (last updated September 27, 2023)
Package information leaflet (PIL): EST  (last updated September 27, 2023)
Labelling:  (last updated March 14, 2017)
Last imported to Estonia: April 16, 2024
Marketing authorization holder: Pfizer Europe MA EEIG 
Marketing authorization number: 056994 
Marketing authorization issued on: December 17, 1999 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: National 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
100  05.04.2024     Yes      No  until 4 years   
90  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Reumatoloog, Pediaater  Yes  from 63 years   
90  05.04.2024     Yes  N00-N08  Nefroloog, Pediaater  No      
100  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Reumatoloog, Pediaater  Yes  until 4 years   
90  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Reumatoloog, Pediaater  Yes      
100  05.04.2024     Yes  Z94-Z94; T86-T86    No  until 4 years   
90  05.04.2024     Yes  N00-N08  Nefroloog, Pediaater  No  from 63 years   
75  05.04.2024     Yes  N00-N08  Nefroloog, Pediaater  No      
90  05.04.2024     Yes  N00-N08  Nefroloog, Pediaater  No      
100  05.04.2024     Yes  Z94-Z94; T86-T86    No      
90  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Pediaater, Reumatoloog  Yes      
90  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Reumatoloog, Pediaater  Yes  4 years - 17 years   
100  05.04.2024     Yes  G35-G35  Pediaater, Neuroloog  Yes  until 4 years   
75  05.04.2024     Yes  M30-M35; M05-M08; M45-M46  Pediaater, Reumatoloog  Yes      
100  05.04.2024     Yes  N00-N08  Pediaater, Nefroloog  No  until 4 years   
100  05.04.2024     Yes  G35-G35  Pediaater, Neuroloog  Yes      
50  05.04.2024     Yes      No      
90  05.04.2024     Yes  N00-N08  Pediaater, Nefroloog  No  4 years - 17 years   
Reference price:   
Under reference price:   
Reference price of daily dose:   
Description Additional condition
Hambaarstil on õigus välja kirjutada
Entry/Changing date: September 27, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere